Egr1 could prompt EMT of non-small cell lung cancer (NSCLC) and gastric cancer cells and activate gastric cancer cells proliferation and invasion by stimulating β-catenin expression [35, 41, 42]. Here, EGR1 is linked to non-small cell lung carcinoma.